Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess whether rotigotine has an effect on the electrical
activity of the heart. Moxifloxacin infusion is used as positive control to assess assay
sensitivity.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Pharma
Treatments:
Moxifloxacin N 0437 Norgestimate, ethinyl estradiol drug combination Rotigotine